Publications by authors named "Daniel Y Reuben"

Claim this Profile
I
Immune mediated hemolysis after Chikungunya viral infection.
Daniel Y Reuben, Eugene H Lewis

IDCases· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Duration Pembrolizumab for Metastatic Undifferentiated Pleomorphic Soft Tissue Sarcoma With Multimodality Therapy.
Daniel Y Reuben

J Med Cases· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium.
Toni K Choueiri, Chris Labaki, Ziad Bakouny, Chih-Yuan Hsu, Andrew L Schmidt, Daniel Y Reuben

Lancet Reg Health Am· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
Douglas B Johnson, Michael B Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman, Daniel Y Reuben

BMC Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
Michael J Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P Shah, Daniel Y Reuben

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
Gino Kim In, Aparna Nallagangula, Jacob Seung Choi, Lisa Tachiki, Matthew J Blackburn, Daniel Y Reuben

J Immunother Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer.
Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Daniel Y Reuben

Cancer Discov· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Developments in Management of Melanoma During the COVID-19 Era.
Andraia R Li, Manuel Valdebran, Daniel Y Reuben

Front Med (Lausanne)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prolonged Response and Characteristics of Trabectedin Treatment of Metastatic Soft Tissue Sarcoma.
Daniel Y Reuben

J Med Cases· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Neeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, Mohammed M Milhem, Elizabeth G Hill, Daniel Y Reuben

Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis